PTGF-β Activators
PTGF-β Activators are a diverse array of chemical compounds that enhance the functional activity of PTGF-β through various biochemical mechanisms. Forskolin and Isoproterenol, by increasing intracellular cAMP levels, lead to the activation of PKA, which can phosphorylate substrates that enhance PTGF-β's receptor interaction and signaling efficacy. IBMX prevents cAMP degradation, maintaining PKA activity and thereby promoting a signaling environment conducive to PTGF-β activity. Similarly, Dibutyryl-cAMP serves as a direct activator of PKA, leading to enhanced PTGF-β signaling. Lithium Chloride and Sodium Butyrate manipulate other pathways such as Wnt and gene expression, respectively, creating a cellular context that augments PTGF-β's role in cellular proliferation and differentiation. Anisomycin, through the activation of JNK, modulates stress responses that can indirectly enhance PTGF-β's functional role in inflammation and cell survival.
The activity of PTGF-β is further influenced by compounds that modulate intracellular calcium levels and proteasome function. Thapsigargin and A-23187 raise intracellular calcium concentrations, thus activating pathways that can enhance PTGF-β's regulatory functions in cell adhesion and motility.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing the levels of cyclic AMP (cAMP) in cells. Elevated cAMP activates protein kinase A (PKA), which can then phosphorylate and activate downstream targets that may include PTGF-β. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and change the activity of various proteins and signaling pathways. PKC activation is known to influence pathways that could potentially enhance the activity of PTGF-β. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate can bind to its receptors, initiating a signaling cascade that often results in the activation of the MAPK/ERK pathway, which could lead to the functional activation of PTGF-β by affecting its downstream targets. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits multiple protein kinases, potentially reducing negative regulatory influences on signaling pathways that activate PTGF-β, thus allowing for its enhanced functional activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter downstream signaling pathways such as AKT, potentially relieving negative feedback loops and enhancing signaling processes that activate PTGF-β. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, and by inhibiting this kinase, it can influence cellular signaling in a way that potentially enhances the activity of PTGF-β. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels and activating calcium-dependent signaling pathways, which could indirectly lead to the enhanced functional activity of PTGF-β. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor, which may enhance the functional activity of PTGF-β by reducing competitive signaling pathways and thus indirectly activating PTGF-β’s associated pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which, by inhibiting certain kinases, might relieve inhibitory effects on the signaling pathways associated with PTGF-β, thus enhancing its activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels, which can activate various calcium-dependent pathways enhancing PTGF-β activity. | ||||||